Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 20, 2022, Harmony Biosciences Holdings, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, stockholders voted on the following three proposals, each of which is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 8, 2022. A total of 51,930,920 shares of the Company's common stock were present electronically or represented by proxy at the Annual Meeting, representing approximately 87.9% percent of the Company's outstanding common stock as of the March 21, 2022 record date.

Proposal 1. The election of the three Class II directors listed below to serve until the Company's 2025 annual meeting of stockholders and until their successors are duly elected and qualified.



                Votes For  % Votes For Withheld  % Votes Withheld Broker Non-Votes
Juan A. Sabater 32,902,197      81.03% 7,701,273           18.97%    11,327,450
Gary Sender     36,685,151      90.35% 3,918,319            9.65%    11,327,450
Linda Szyper    40,548,477      99.86%  54,993              0.14%    11,327,450

Based on the votes set forth above, each of the director nominees was duly elected.

Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.

Votes For Votes Against Abstain

51,903,095 16,186 11,639

Based on the votes set forth above, the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 was duly ratified.

Proposal 3. The approval on a non-binding, advisory basis, of the frequency of future advisory votes, following the first annual meeting during which the Company holds such a vote, on the compensation of the Company's named executive officers pursuant to the SEC's compensation disclosure rules.



 3 Years   2 Years   1 Year   Broker Non-Votes
23,586,231 35,672  16,964,757    11,327,450

Based on the votes set forth above, the selection of 3 Years as the frequency of future advisory votes on the compensation of the Company's named executive officers, following the first annual meeting during which the Company holds such a vote, has been approved.

© Edgar Online, source Glimpses